CEO of Serum Institute India (SII) Adar Poonawalla announced a price reduction for Covid-19 vaccines for states in India, in a measure to save state funds.
He tweeted Wednesday saying that as a philanthropic gesture on behalf of the institute, “I hereby reduce the price to the states from Rs.400 to Rs.300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives.”
Some context: The reduction is approximately equivalent to going from US $5.30 per dose to US $4 per dose.
SII manufactures Oxford/AstraZeneca’s Covishield vaccine.